Streptozotocin (NSC-85998) in children with acute lymphocytic leukemia. A Southwest Oncology Group study.
Streptozotocin (NSC-85998), a nitrosourea antibiotic, was given to 18 children with acute lymphocytic leukemia in relapse in a dose of 500 mg/m2/day intravenously every day for five days. There were no responses in 14 fully evaluable patients. The principal toxicity consisted of gastrointestinal disturbances. Based on our findings and those of others in adults, steptozotocin appears to play no role in the management of acute lymphocytic leukemia.
D002648:Child; D004341:Drug Evaluation; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D013311:Streptozocin / Q000009:adverse effects / Q000627:therapeutic use*
D013311:Streptozocin